1. Home
  2. BLNK vs ACIU Comparison

BLNK vs ACIU Comparison

Compare BLNK & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blink Charging Co.

BLNK

Blink Charging Co.

HOLD

Current Price

$0.53

Market Cap

86.2M

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

N/A

Current Price

$2.66

Market Cap

247.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLNK
ACIU
Founded
2009
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.2M
247.6M
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
BLNK
ACIU
Price
$0.53
$2.66
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$2.33
$10.00
AVG Volume (30 Days)
1.1M
180.6K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
61.22
N/A
EPS
N/A
N/A
Revenue
$126,197,000.00
N/A
Revenue This Year
$5.71
$706.75
Revenue Next Year
$19.65
$321.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$2.10
52 Week High
$2.65
$4.00

Technical Indicators

Market Signals
Indicator
BLNK
ACIU
Relative Strength Index (RSI) 43.68 53.18
Support Level $0.51 $2.57
Resistance Level $0.62 $3.00
Average True Range (ATR) 0.03 0.12
MACD -0.00 -0.02
Stochastic Oscillator 27.17 35.71

Price Performance

Historical Comparison
BLNK
ACIU

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The Blink's principal line of products and services is its Blink EV charging networks, Blink EV charging equipment, and other EV-related services. The Blink Network is a proprietary, cloud-based system that operates, maintains, and manages Blink charging stations and handles the associated charging data, back-end operations, and payment processing. The Blink Network provides fleets, property owners, managers, parking companies, and state and municipal entities, among other types of commercial customers, with cloud-based services.

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: